Bleakley Financial Group, LLC Amarin Corp Plcuk Transaction History
Bleakley Financial Group, LLC
- $3.32 Trillion
- Q4 2024
A detailed history of Bleakley Financial Group, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 468,848 shares of AMRN stock, worth $276,620. This represents 0.01% of its overall portfolio holdings.
Number of Shares
468,848
Previous 468,848
-0.0%
Holding current value
$276,620
Previous $294 Million
22.64%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding AMRN
# of Institutions
182Shares Held
71.1MCall Options Held
183KPut Options Held
66.7K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$14.7 Million3.7% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$7.32 Million0.38% of portfolio
-
Morgan Stanley New York, NY4.41MShares$2.6 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.48 Million1.0% of portfolio
-
Waterfront Wealth Inc.2.48MShares$1.46 Million0.31% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $238M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...